Informed consent to opioid agonist maintenance treatment: Recommended ethical guidelines

International Journal of Drug Policy

Volumn 19, Issue 1, 2008, Pages 79-89

  Carter, Adrian ^a   Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Addiction; Agonist maintenance; Autonomy; Informed consent; Opioids

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; OPIATE AGONIST;

ARTICLE; HEALTH PROGRAM; HEROIN DEPENDENCE; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MENTAL HEALTH; OPIATE ADDICTION; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; URINALYSIS;

DECISION MAKING; GUIDELINE ADHERENCE; HARM REDUCTION; HUMANS; INFORMED CONSENT; NARCOTICS; OPIOID-RELATED DISORDERS; PERSONAL AUTONOMY; RECEPTORS, OPIOID; RESEARCH SUBJECTS;

EID: 39049099508     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.09.007     Document Type: Article

References (62)

1. Adler M.W. Human subject issues in drug-abuse research. Drug and Alcohol Dependence 37 2 (1995) 167-175
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. (1994), American Psychiatric Association, Washington, DC
3. Bechara A. Neurobiology of decision-making: Risk and reward. Seminars in Clinical Neuropsychiatry 6 3 (2001) 205-216
4. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience 8 11 (2005) 1458-1463
5. Bell J. Delivering effective methadone treatment. In: Ward P., Mattick R.P., and W. Hall W. (Eds). Methadone maintenance treatment and other opioid replacement therapies (1998), Harwood Academic Press, Sydney 161-175
6. Bell J., Chan J., and Kuk A. Investigating the effect of treatment philosophy on outcome of methadone maintenance. Addiction 90 (1995) 823-830
7. Cairns R., Maddock C., Buchanan A., David A.S., Hayward P., Richardson G., et al. Reliability of mental capacity assessments in psychiatric in-patients. British Journal of Psychiatry 187 (2005) 372-378
8. Caplan A. No brainer: We can cope with the ethical ramifications of new knowledge of the human brain. In: Marcus S. (Ed). Neuroethics: Mapping the field (2002), The Dana Press, San Francisco 95-131
9. Caplan A.L. Ethical issues surrounding forced, mandated, or coerced treatment. Journal of Substance Abuse Treatment 31 2 (2006) 117-120
10. Carter A., and Hall W. The social implications of neurobiological explanations of resistible compulsions. American Journal of Bioethics 7 1 (2007) 15-17
11. Charland L.C. Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics 2 2 (2002) 37-47
12. Cohen P.J. Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. Journal of Law Medicine & Ethics 30 1 (2002) 73-81
13. Curran H.V. Benzodiazepines, memory and mood: A review. Psychopharmacology (Berl) 105 1 (1991) 1-8
14. Curran H.V., Kleckham J., Bearn J., Strang J., and Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study. Psychopharmacology (Berl) 154 2 (2001) 153-160
15. Dackis C.A., and O'Brien C. Neurobiology of addiction: Treatment and public policy ramifications. Nature Neuroscience 8 11 (2005) 1431-1436
16. Dalrymple T. Romancing opiates: Pharmacological lies and the addiction bureaucracy (2006), Encounter Books, New York
17. Dunn L.B., and Jeste V.P. Enhancing informed consent for research and treatment. Neuropsychopharmaoclogy 24 6 (2001) 595-607
18. Dunn L.B., Nowrangi M.A., Palmer B.W., Jeste D.V., and Saks E.R. Assessing decisional capacity for clinical research or treatment: A review of instruments. American Journal of Psychiatry 163 8 (2006) 1323-1334
19. Elliott C. Who holds the leash?. American Journal op Bioethics 2 2 (2002) 48
20. Faden R.R., Beauchamp T.L., and King N.M. A history and theory of informed consent (1986), Oxford University Press, New York
21. Fillmore M.T. Drug abuse as a problem of impaired control: Current approaches and findings. Behavioural and Cognitive Neuroscience Reviews 2 3 (2003) 179-197
22. Finnigan F., and Hammerslay R. The effect of alcohol on performance. In: Smith A.P., and Jones D.M. (Eds). Handbook of human performance: Health and performance Vol. 2 (1992), Academic Press, London 73-126
23. Foddy B., and Savulescu J. Addiction and autonomy: Can addicted people consent to the prescription of their drug of addiction?. Bioethics 20 1 (2006) 1-15
24. Forman R.F., Bovasso G., Woody G., Mcnicholas L., Clark C., Royer-Malvestuto C., et al. Staff beliefs about drug abuse clinical trials. Journal of Substance Abuse Treatment 23 1 (2002) 55-60
25. Fureman I., Meyers K., McLellan A.T., Metzger D., and Woody G. Evaluation of a video-supplement to informed consent: Injection drug users and preventive HIV vaccine efficacy trials. AIDS Education and Prevention 9 4 (1997) 330-341
26. Gerstein D.R., and Harwood H.J. Treating drug problems (volume 1): A study of effectiveness and financing of public and private drug treatment systems (1990), Institute of Medicine, National Academy Press, Washington, DC
27. Gorelick D., Pickens R.W., and Benkovsky F.O. Clinical research in substance abuse: Human subjects issues. In: Pinchus H.A., Lieberman J.A., and Ferris S. (Eds). Ethics in psychiatric research: A resource manual for human subjects protection (1999), American Psychiatric Association, Washington, DC 177-194
28. Gowing, L., Ali, R., & White, J. (2006). Buprenorphine for the management of opioid withdrawal. Cochrane Database System Reviews, Issue 2. Art. No.: CD002025. doi:10.1002/14651858.CD002025.pub3.
29. Grant S., Contoreggi C., and London E.D. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 38 8 (2000) 1180-1187
30. Grisso T., and Applebaum P.S. Assessing competence to consent to treatment: A guide for physicians and other health professionals (1998), Oxford University Press, New York
31. Hall W. Avoiding potential misuses of addiction brain science. Addiction 101 (2006) 1529-1532
32. Hall, W., Doran, C., Degenhardt, L., & Shepard, D. (2006). Illicit opiate use. In Disease control priorities in developing countries (pp. 907-931). New York: Oxford University Press.
33. Harrison K., Vlahov D., Jones K., Charron K., and Clements M.L. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 10 3 (1995) 386-390
34. Hazelton L.D., Sterns G.L., and Chisholm T. Decision-making capacity and alcohol abuse: Clinical and ethical considerations in personal care choices. General Hospital Psychiatry 25 2 (2003) 130-135
35. Hotopf M. The assessment of mental capacity. Clinical Medicine 5 6 (2005) 580-584
36. Jentsch J.D., and Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology 146 4 (1999) 373-390
37. Leshner A.I. Addiction is a brain disease, and it matters. Science 278 5335 (1997) 45-47
38. Lyvers M., and Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addictive Behaviors 28 3 (2003) 605-611
39. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database System Reviews, Issue 2. Art. No.: CD002209. doi:10.1002/14651858.CD002209.
40. Mattick R.P., and Hall W. Are detoxification programmes effective?. Lancet 347 8994 (1996) 97-100
41. McCrady B.S., and Bux Jr. D.A. Ethical issues in informed consent with substance abusers. Journal of Consulting and Clinical Psychology 67 2 (1999) 186-193
42. Mintzer M.Z., Copersino M.L., and Stitzer M.L. Opioid abuse and cognitive performance. Drug and Alcohol Dependence 78 2 (2005) 225-230
43. Olds J., and Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative Physiological Psychology 47 6 (1954) 419-427
44. Perneger T.V., Giner F., Del Rio M., and Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal 317 7150 (1998) 13-18
45. Rapeli P., Kivisaari R., Autti T., Kahkonen S., Puuskari V., Jokela O., et al. Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry 6 (2006) 9
46. Roberts L.W. Addiction and consent. American Journal of Bioethics 2 2 (2002) 58-60
47. Roberts L.W. Informed consent and the capacity for voluntarism. American Journal of Psychiatry 159 5 (2002) 705-712
48. Rogers R.D., and Robbins T.W. Investigating the neurocognitive deficits associated with chronic drug misuse. Current Opinion in Neurobiology 11 2 (2001) 250-257
49. Smith K.L., Horton N.J., Saitz R., and Samet J.H. The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug and Alcohol Dependence 82 3 (2006) 231-237
50. Spriggs M. Autonomy and patients' decisions (2005), Lexington Books, Lanham
51. Sugarman J., McCrory D.C., Powell D., Krasny A., Adams B., Ball E., et al. Empirical research on informed consent-An annotated bibliography. Hastings Center Report 29 1 (1999) S1
52. Szasz T. Ceremonial chemistry: The ritual persecution of drugs, addicts and pushers. Revised ed. (1997), Learning Publications, Holmes Beach, FL
53. Trafton J.A., Minkel J., and Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Medicine 3 3 (2006) e80
54. Volkow N.D., and Fowler J.S. Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex 10 3 (2000) 318-325
55. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigation 111 10 (2003) 1444-1451
56. Volkow N.D., and Li T.K. Drug addiction: The neurobiology of behaviour gone awry. Nature Reviews Neuroscience 5 12 (2004) 963-970
57. Volkow N.D., and Li T.K. The neuroscience of addiction. Nature Neuroscience 8 11 (2005) 1429-1430
58. Volkow N.D., and Li T.K. Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences. Pharmacology & Therapeutics 108 1 (2005) 3-17
59. Walker R., Logan T.K., Clark J.J., and Leukefeld C. Informed consent to undergo treatment for substance abuse: A recommended approach. Journal of Substance Abuse Treatment 29 4 (2005) 241-251
60. Ward J., Mattick R.P., and Hall W. Key issues in methadone maintenance treatment (1992), New South Wales University Press, Kensington, NSW
61. Ward P., Mattick R.P., and Hall W. Methadone maintenance treatment and other opioid replacement therapies (1998), Harwood Academic Press, Sydney
62. Yucel M., and Lubman D.I. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: Implications for diagnosis, treatment and prevention. Drug and Alcohol Review 26 1 (2007) 33-39